Haase et al. [35] showed that certain rare APOA1 allelic variants (e.g., the A164S variant) determine a predisposition to amyloidosis associated with low plasma levels of ApoA-I and HDL-C, with carriers having an increased risk of CVD and CAD, in a study performed on the Danish population. This evidence concerns the gene APOA1 and coronary artery disorder.